Week 1 - Quiz | NURS 6521 - Advanced Pharmacology

Review Test Submission: Week 1 - Quiz Content User Roan Forgie Course NURS-6521N-22,Advanced Pharmacology.2018 Fall Quarter 08/27-11/18-

PT27

Test Week 1 - Quiz Started 9/1/18 6:01 PM Submitted 9/1/18 7:38 PM Due Date 9/3/18 1:59 AM Status Completed Attempt Score 38 out of 40 points 2 Time Elapsed 1 hour, 36 minutes out of 1 hour and 40 minutes

Instructions Please answer each question below and click Submit when you have

completed the Quiz. Results Displayed Feedback

Question 1

1 out of 1 points A patient has been receiving regular doses of an agonist for 2 weeks. Which of the following should the nurse anticipate? Response

Feedback:

Receptors are not static; they can change or modify their response to a stimulus. Such change occurs when a receptor is continuously stimulated to act or continually inhibited from action. Continual stimulation from an agonist usually makes the receptor desensitized to the drug and thus less active. Therefore, the nurse should anticipate a decrease in effectiveness of the drug.

Question 2

1 out of 1 points A nurse is discussing with a patient the efficacy of a drug that his physician has suggested, and he begin taking. Efficacy of a drug means which of the following? Response

Feedback:

Efficacy indicates how well a drug produces its desired effect. Different drugs have different strengths of attraction or affinity for receptor sites. A drug's ability to stimulate its receptor is called its intrinsic activity, and the amount of a drug that must be given to produce a particular response is called the potency of a drug.

Question 3

1 out of 1 points An older adult patient with a history of Alzheimer's disease and numerous chronic health problems has been prescribed several medications during his current admission to hospital and recent declines in the patient's cognition have impaired his ability to swallow pills. Which of the following medications may the nurse crush before administering them to this patient? Response

Feedback:

A tablet that is designed for immediate release into the gastric environment is normally safe to crush and administer to the patient. Enteric coated and sustained release tablets may not be crushed because doing so compromising